Artificial Cell Bioencapsulation in Macro, Micro, Nano, and Molecular Dimensions: Keynote Lecture

References

• Aebischer P., Schluep M., Deglon N., Joseph J. M, Hirt L., Heyd B., Goddard M., Hammang J. P., Zurn A. D., Kato A. C., Regli F., Baetge E. E. Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients. Nat. Med. 1996; 2: 696–699, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Bourget L., Chang T. M. S. Phenylalanine ammonia-lyase immobilized in microcapsules for the depleture of phenylalanine in plasma in phenylketonuric rat model. Biochim. Biophys. Acta 1986; 883: 432–438, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Bruni S., Chang T. M. S. Hepatocytes immobilized by microencapsulation in artificial cells: Effects on hyperbiliru-binemia in Gunn Rats. J. Biomat. Artif. Cells and Artif. Org. 1989; 17: 403–412
   PubMedGoogle Scholar
• Chang T. M. S. ‘Hemoglobin Corpuscles’, Report of a research project for Honours Physiology, Medical Library, McGill University. Also reprinted as part of ‘30 anniversary in artificial red blood cells research’. J. Biomaterials, Artificial Cells & Artificial Organs 1957; 16: 1–9, 1988[INFOTRIEVE]
   Google Scholar
• Chang T. M. S. Semipermeable microcapsules. Science 1964; 146: 524–525, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Chang T. M. S. Semipermeable aqueous microcapsules [“artificial cells”]: with emphasis on experiments in an extracorporeal shunt system. Trans. Am. Soc. Artif. Intern. Organs 1966; 12: 13–19, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Chang T. M. S. The in vivo effects of semipermeable microcapsules containing L-asparaginase on 6C3HED lymphosarcoma. Nature 1971a; 229(528)117–118, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Chang T. M. S. Stabilization of enzyme by microencapsulation with a concentrated protein solution or by crosslinking with glutaraldehyde. Biochem. Biophys. Res. Com. 1971b; 44: 1531–1533, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Chang T. M. S. Artificial Cells. Thomas Publisher, Springfield, C.C. 1972; pp. 1–207, (Available for free online viewing at www.artcell.mcgill.ca)
   Google Scholar
• Chang T. M. S. Microencapsulated adsorbent hemoperfusion for uremia, intoxication and hepatic failure. Kidney Int. 1975; 7: S387–S392
   Web of Science ®Google Scholar
• Chang T. M. S. Biodegradable semipermeable microcapsules containing enzymes, hormones, vaccines, and other biologicals. J. Bioengineering 1976; 1: 25–32
   PubMedGoogle Scholar
• Chang T. M. S. Artificial cells with emphasis on bioencapsulation in biotechnology. Biotechnology Annual Review 1995; 1: 267–295, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Chang T. M. S. Artificial cells. Encyclopedia of Human Biology. 2nd Ed., Renals Dulbecco. Academic Press Inc., San Diego, CA 1997a; pp. 457–463
   Google Scholar
• Chang T. M. S. Live E. coli cells to treatment uremia: replies to letters to the editor. Nature Medicine 1997b; 3: 2–3, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Chang T. M. S. Blood Substitutes: Principles, Methods, Products and Clinical Trials. Karger, Basel 1997c; Vol. 1: pp. 1–138, (available for free online viewing at www. artcell.mcgill.ca)
   Google Scholar
• Chang T. M. S. Artificial blood: a prospective. Trends in Biotechnology 1999; 17: 61–67, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Chang T. M. S. Bioencapsulated hepatocytes for experimental liver support. Journal of Hepatology 2001; 34: 148–149, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Chang T. M. S. Oxygen carriers. Current Opinion in Investigational Drugs 2002; 3(8)1187–1190, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Chang T. M. S. New generations of red blood cell substitutes. J. Internal Medicine. 2003; 253: 527–535, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Chang T. M. S., Poznansky M. J. Semipermeable microcapsules containing catalase for enzyme replacement in acatalsaemic mice. Nature 1968; 218(5138)242–245
   Web of Science ®Google Scholar
• Chang T. M. S., Prakash S. Therapeutic uses of microencapsulated genetically engineered cells. Molecular Medicine Today 1998; 4: 221–227, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Chang T. M. S., Prakash S. Procedure for microencapsulation of enzymes, cells and genetically engineered microorganisms. Molecular Biotechnology 2001; 17: 249–260, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Chang T. M. S., Yu W. P. Nanoencapsulation of hemoglobin and red blood cell enzymes based on nanotechnology and biodegradable polymer. Blood Substitutes: Principles, Methods, Products and Clinical Trials, T. M. S. Chang. Karger, Basel 1998; Vol. 2: pp. 216–231
   Google Scholar
• Chang T. M. S., Bourget L., Lister C. New theory of enterorecirculation of amino acids and its use for depleting unwanted amino acids using oral enzyme-artificial cells, as in removing phenylalanine in phenylketonuria. Artificial Cells, Blood Substitutes & Immobilization Biotechnology 1995; 25: 1–23
   Google Scholar
• Chang T. M. S., MacIntosh F. C., Mason S. G. Semipermeable aqueous microcapsules: I. Preparation and properties. Can. J. Physiol. Pharmacol. 1966; 44: 115–128, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Chang T. M. S., Powanda D., Yu W. P. Analysis of polyethylene-glycol-polylactide nano-dimension artificial red blood cells in maintaining systemic hemoglobin levels and prevention of methemoglobin formation. Artif. Cells, Blood Substitutes & Biotechnology, An International Journal 2003; 31(3)231–248, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Chow K. M., Liu Z. C., Prakash S., Chang T. M. S. Free and icroencapsulated Lactobacillus and effects of metabolic induction on Urea Removal Artificial Cells. Blood Substitutes & Biotechnology 2003; 33: 425–434, in press, [CROSSREF]
   Google Scholar
• D’Agnillo F., Chang T. M. S. Polyhemoglobin-superoxide dismutase, catalase as a blood substitute with antioxidant properties. Nature Biotechnology 1998a; 16(7)667–671, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• D'Agnillo F., Chang T. M. S. Absence of hemoprotein-associated free radical events following oxidant challenge of crosslinked hemoglobin-superoxide dismutase-catalase. Free Radical Biology & Medicine 1998b; 24(6)906–912, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Dionne K. E., Cain B. M., Li R. H., Bell W. J., Doherty E. J., Rein D. H., Lysaght M. J., Gentile F. T. Transport characterization of membranes for immunoisolation. Biomaterials 1996; 17: 257–266, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Gould S. A., Sehgal L. R., Sehgal H. L., DeWoskin R., Moss G. S. The clinical development of human polymerized hemoglobin. Blood Substitutes: Principles, Methods, Products and Clinical Trials, T. M. S. Chang. Karger, Basel 1998; Vol. 2: pp. 12–28
   Google Scholar
• Gould S. A., Moore E. E., Hoyt D. B., Ness P. M., Norris E. J., Carson J. L., Hides GA., Freeman I. H. G., DeWoskin R., Moss G. S. The life-sustaining capacity of human polymerized hemoglobin when red cells might be unavailable. Journal of the American College of Surgeons 2002; 195: 445–452, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Bioartificial Organs A: Technology, Medicine and Material, D. Hunkeler, A., A. D. Prokop, R. Rajotte, M. Sefton. Ann N.Y. Acad. Sci. 1999; Vol. 875: pp. 271–279, (1999). Acad. Sci., 831
   Google Scholar
• Cell Encapsulation Technology and Therapy, W. M. Kulitreibez, P. P. Lauza, W. L. Cuicks. Burkhauser, Boston 1999; pp. 1–450
   Google Scholar
• Lim F., Sun A. M. Microencapsulated islets as bioartificial endocrine pancreas. Science 1980; 210: 908–909, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Liu Z., Chang T. M. S. Effects of bone marrow cells on hepatocytes: when co-cultured or co-encapsulated together. Artif Cells, Blood Substitutes & Immob. Biotechnology, An International Journal 2000; 28(4)365–374
   PubMed Web of Science ®Google Scholar
• Liu Z. C., Chang T. M. S. Transplantation of co-encapsulated hepatocytes and marrow stem and cells into rats. Artificial Cells, Blood Substitutes & Immob. Biotechnology, An International Journal 2002; 30: 99–112, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Liu Z. C., Chang T. M. S. Coencapsulation of stem cells and hepatocytes: in-vitro conversion of ammonia and in-vivo studies on the lowering of bilirubin in gunn rats after transplantation. Interantional Journal of Artificial Organs 2003; 26(6)491–497
   PubMed Web of Science ®Google Scholar
• Liu J., Jia X., Zhang J., Xiang G., Hu W., Zhou Y. Study on a novel strategy to treatment of phenylketonuria. Artificial Cells, Blood Substitutes & Immobilization Biotechnology 2002; 30: 243–258, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Orive G., Hernandez R. M., Gascon A. R., Calafiore R., Chang T. M. S. Cell encapsulation: promise and progress. Nature Medicine 2003; 9: 104–107, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Palmour R. M., Goodyer P., Reade T., Chang T. M. S. Microencapsulated xanthine oxidase as experimental therapy in Lesch-Nyhan Disease. Lancet 1989; 2(8664)687–688, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Pearce L. B., Gawryl M. S. Overview of preclinical and clinical efficacy of biopure's HBOCs. Blood Substitutes: Principles, Methods, Products and Clinical Trials, T. M. S. Chang. Karger, Basel 1998; Vol. 2: pp. 82–98
   Google Scholar
• Philips W. T., Klpper R. W., Awasthi V. D., Rudolph A. S., Cliff R., Kwasiborski V. V., Goins B. A. Polyethylene glyco-modified liposome-encapsulated hemoglobin: a long circulating red cell substitute. J. Pharm. Exp. Therapeutics 1999; 288: 665–670, [CSA]
   PubMed Web of Science ®Google Scholar
• Powanda D., Chang T. M. S. Cross-linked polyhemoglobin-superoxide dismutase-catalase supplies oxygen without causing blood brain barrier disruption or brain edema in a rat model of transient global brain ischemia-reperfusion. Artificiall Cells, Blood Substitutes & Immob. Biotechnology, An International Journal 2002; 30: 25–42, [CSA]
   Google Scholar
• Poznansky M. J., Chang T. M. S. Comparison of the enzyme kinetics and immunological properties of catalase immobilized by microencapsulation and catalase in free solution for enzyme replacement. Biochim. Biophys. Acta 1974; 334: 103–115
   Web of Science ®Google Scholar
• Prakash S., Chang T. M. S. Microencapsulated genetically Engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats. Nature Medicine 1996; 2(8)883–887, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Razack S., D'Agnillo F., Chang T. M. S. Effects of Polyhemoglobin-catalase-superoxide dismutase on oxygen radicals in an ischemia-reperfusion rat intestinal model. Artificial Cells, Blood Substitutes and Immobilization Biotechnology. 1997; 25: 181–192, [CSA]
   PubMed Web of Science ®Google Scholar
• Red Blood Cell Substitutes, A. S. Rudolph, R. Rabinovici, G. Z. Feuerstein. Marcel Dekker Inc, N.Y. 1997; pp. 1–485
   Google Scholar
• Sarkissian C. N., Shao Z., Blain F., Peevers R., Su H., Heft R., Chang T. M. S., Scriver C. R. A different approach to treatment of phenylketonuria: phenylalanine degradation with recombinant phenylalanine ammonia lyase. Proc. Natl. Acad. Sci. 1999; 96: 2339–2344, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Sprung J., Kindscher J. D., Wahr J. A., Levy J. H., Monk T. G., Moritz M. W., O'Hara P. J. The use of bovine hemoglobin glutamer-250 (Hemopure) in surgical patients: results of a multicenter, randomized, single-blinded trial. Anesth. Analg. 2002; 94: 799–808, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Blood Substitutes: Present and Future Perspectives, E. Tsuchida. Elsevier, Amsterdam 1998; pp. 1–267
   Google Scholar
• Winchester J. F. Replacement of renal function by dialysis. Hemoperfusion, J. F. Maher. Kluwer Academic Publisher, Boston 1988; pp. 439–592
   Google Scholar
• Winslow R. Current status of blood substitute research: towards a new paradigm. J. Int. Med. 2003; 253: 508–517, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Wong H., Chang T. M. S. Bioartificial liver: implanted artificial cells microencapsulated living hepatocytes increases survival of liver failure rats. Int. J. Artif Organs 1986; 9: 335–336, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Wong H., Chang T. M. S. The viability and regeneration of artificial cell microencapsulated rat hepatocyte xenograft transplants in mice. J. Biomaterials, Artificial Cells and Artificial Organs 1988; 16: 731–740
   PubMedGoogle Scholar
• Wong H., Chang T. M. S. Microencapsulation of cells within alginate poly-L-lysine microcapsules prepared with standard single step drop technique: histologically identified membrane imperfections and the associated graft rejection. Biomaterials, Artificial Cells and Immobilization Biotechnology 1991a; 19: 675–686, [CSA]
   PubMed Web of Science ®Google Scholar
• Wong H., Chang T. M. S. A novel two-step procedure for immobilizing living cells in microcapsule for improving xenograft survival. Biomaterials, Artificial Cells and Immobilization Biotechnology 1991b; 19: 687–698, [CSA]
   PubMed Web of Science ®Google Scholar
• Yu W. P., Chang T. M. S. Submicron biodegradable polymer membrane hemoglobin nanocapsules as potential blood substitutes: A preliminary report. J. of Artificial Cells, Blood Substitutes and Immobilization Biotechnology (Guest editor: R. Winslow) 1994; 22: 889–894
   PubMed Web of Science ®Google Scholar
• Yu B. L., Chang T. M. S. Effects of combined oral administration and intravenous injection on maintaining decreased systemic tyrosine levels in rats. Artificial Cells, Blood Substitutes & Biotechnology, An International Journal 2004; 34: 129–147, in this issue[CROSSREF]
   Google Scholar
• Yu W. P., Wong J., Chang T. M. S. Preparation and characterization of polylactic acid microcapsules containing ciprofloxacin for controlled release. J. Microencapsulation 1998; 15: 515–523, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Yu W. P., Wong J. P., Chang T. M. S. Biodegradable polylactic acid nanocapsules containning ciprofloxacin: preparation and characterization. Artif Cells, Blood Substitutes & Immob. Biotechnology, An International Journal 1999; 27(3)263–278, [CSA]
   PubMed Web of Science ®Google Scholar